Clinical Trial Update: Silymarin in COVID-19 Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for silymarin in COVID-19 pneumonia is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Pneumonia Human Coronavirus

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: Cairo University | Conditions: COVID-19, Viral Pneumonia Human Coronavirus | Phase 3 | Status: UNKNOWN